Caangay, Teresita .

HRN: 22-95-88  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/27/2023
CEFTAZIDIME 1GM (VIAL)
04/27/2023
05/03/2023
IV
1g
Q8
Pneumonia - Severe
Waiting Final Action 
04/28/2023
REMDESIVIR 100MG (VIAL)
04/28/2023
05/07/2023
IV
200mg Now, Then 100mg OD
OD
COVID-19
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: